SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/303474"
 

Search: onr:"swepub:oai:gup.ub.gu.se/303474" > Neurofilament light...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Weinhofer, Isabelle (author)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-03-22
  • Springer Science and Business Media LLC,2021

Numbers

  • LIBRIS-ID:oai:gup.ub.gu.se/303474
  • https://gup.ub.gu.se/publication/303474URI
  • https://doi.org/10.1038/s41467-021-22114-2DOI

Supplementary language notes

  • Language:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • X-linked adrenoleukodystrophy (X-ALD), the most frequent monogenetic disorder of brain white matter, is highly variable, ranging from slowly progressive adrenomyeloneuropathy (AMN) to life-threatening inflammatory brain demyelination (CALD). In this study involving 94 X-ALD patients and 55 controls, we tested whether plasma/serum neurofilament light chain protein (NfL) constitutes an early distinguishing biomarker. In AMN, we found moderately elevated NfL with increased levels reflecting higher grading of myelopathy-related disability. Intriguingly, NfL was a significant predictor to discriminate non-converting AMN from cohorts later developing CALD. In CALD, markedly amplified NfL levels reflected brain lesion severity. In rare cases, atypically low NfL revealed a previously unrecognized smoldering CALD disease course with slowly progressive myelin destruction. Upon halt of brain demyelination by hematopoietic stem cell transplantation, NfL gradually normalized. Together, our study reveals that blood NfL reflects inflammatory activity and progression in CALD patients, thus constituting a potential surrogate biomarker that may facilitate clinical decisions and therapeutic development.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Rommer, Paulus (author)
  • Zierfuss, Bettina (author)
  • Altmann, Patrick (author)
  • Foiani, Martha (author)
  • Heslegrave, Amanda (author)
  • Zetterberg, Henrik,1973Gothenburg University,Göteborgs universitet,Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi,Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry(Swepub:gu)xzethe (author)
  • Gleiss, Andreas (author)
  • Musolino, Patricia L (author)
  • Gong, Yi (author)
  • Forss-Petter, Sonja (author)
  • Berger, Thomas (author)
  • Eichler, Florian (author)
  • Aubourg, Patrick (author)
  • Köhler, Wolfgang (author)
  • Berger, Johannes (author)
  • Göteborgs universitetInstitutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi (creator_code:org_t)

Related titles

  • In:Nature communications: Springer Science and Business Media LLC12:12041-1723

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view